Homepage

Assertio Holdings, Inc.

ASRT NASDAQ Categories PDF
Healthcare · Drug Manufacturers - Specialty & Generic · United States · Updated May 11, 1:50pm
$22.49
Price
$145.0M
Market Cap
58
Employees
0.45
Beta
Mark L. Reisenauer
CEO
Business Description

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.

Business History
Price Overview
Last updated: May 11, 2026 1:51pm (just now)
$22.49
-0.01 (-0.04%)
Day Range
$22.38 – $22.58
52-Week Range
$8.61 – $22.58
50-Day MA
$16.66
200-Day MA
$12.96
Volume
149,304.17
Analyst Price Targets
Low $18.00
Consensus $19.90
High $21.80
(6 analysts)
Share Structure
Outstanding 6,445,160.00
Float 5,625,788.00
Free Float 87.3%
High free float — 87.3% of shares trade freely, ~12.7% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Small absolute float (5.6M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-4.74
Stock Price: $22.49
EPS (Diluted): -4.74
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
0.62
Stock Price: $22.49
Total Equity: $93.95M
Shares: 6,403,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-65.12
Market Cap: $144.95M
Total Debt: $39.12M
Cash: $10.23M
EBITDA: $12.78M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$87.0M
Market Cap: $144.95M
Total Debt: $39.12M
Cash: $10.23M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
70.2%
Gross Profit: $83.33M
Revenue: $118.71M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-18.1%
Operating Income: -$21.54M
Revenue: $118.71M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-24.9%
Net Income: -$29.51M
Revenue: $118.71M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-37.7%
Net Income: -$29.51M
Total Equity: $93.95M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-20.2%
Operating Income: -$21.54M
Tax Rate: 1.5%
Equity: $93.95M
Total Debt: $39.12M
Cash: $10.23M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
1.70
Current Assets: $216.65M
Current Liabilities: $127.51M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.42
Short-Term Debt: $0.00
Long-Term Debt: $39.12M
Total Debt: $39.12M
Total Equity: $93.95M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$18.54
Revenue: $118.71M
Shares: 6,403,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$14.67
Total Equity: $93.95M
Shares: 6,403,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-4.40
Operating CF: -$28.18M
CapEx: $0.00
Shares: 6,403,000
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $22.49
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$29.51M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares ASRT against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $111.0M $156.2M $152.1M $125.0M $118.7M
Cost of Revenue $15.8M $18.7M $27.0M $39.2M $35.4M
Gross Profit $95.2M $137.5M $125.0M $85.7M $83.3M
Operating Expenses $85.8M $98.1M $368.6M $110.2M $104.9M
Operating Income $9.4M $39.4M -$243.5M -$24.5M -$21.5M
Net Income -$1.3M $109.6M -$331.9M -$21.6M -$29.5M
EBITDA $38.8M $90.2M $53.2M $5.1M $12.8M
EPS $-0.45 $34.95 $-70.05 $-3.45 $-4.74
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $36.8M $64.9M $73.4M $50.6M $10.2M
Total Current Assets $103.5M $132.3M $171.1M $202.5M $216.6M
Total Assets $326.5M $413.9M $286.4M $284.7M $267.0M
Current Liabilities $135.0M $95.3M $93.4M $114.7M $127.5M
Long-Term Debt $61.3M $66.4M $38.2M $38.8M $39.1M
Total Liabilities $224.1M $188.2M $148.4M $163.7M $173.0M
Total Equity $102.4M $225.7M $138.0M $121.1M $94.0M
Retained Earnings -$429.2M -$319.6M -$651.5M -$673.1M -$703.5M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $5.5M $78.6M $49.6M $26.4M -$28.2M
Capital Expenditure $-53,000 $-274,000 $-628,000 $0 $0
Free Cash Flow $5.5M $78.3M $49.0M $26.4M -$28.2M
Acquisitions (net) -$18.5M -$42.4M $1.5M $0 $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $-418,000 $-838,000 -$7.9M $-350,000 $0
Net Change in Cash $16.0M $28.1M $8.5M -$22.9M -$40.4M
Analyst Estimates (Annual)
Metric 2027 2028 2029 2030
Revenue $115.2M
$100.9M – $123.1M
 $102.9M
$90.1M – $109.9M
 $114.6M
$100.4M – $122.4M
 $122.7M
$107.5M – $131.1M
EBITDA $32.8M
$28.8M – $35.1M
 $29.3M
$25.7M – $31.3M
 $32.6M
$28.6M – $34.9M
 $35.0M
$30.6M – $37.4M
Net Income $2.7M
$2.4M – $3.1M
 $11.2M
$9.2M – $12.0M
 $18.4M
$15.4M – $20.0M
 $24.2M
$20.3M – $26.4M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth +40.7% -2.7% -17.8% -5.0%
Gross Profit Growth +44.4% -9.0% -31.4% -2.8%
Operating Income Growth +318.1% -718.0% +89.9% +12.0%
Net Income Growth +8,657.8% -402.8% +93.5% -36.7%
EBITDA Growth +132.5% -41.0% -90.3% +148.4%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-05-05 Stark David Matthew A-Award 4,851.00 $0.00 $0
2026-05-05 Emany Sravan Kumar A-Award 4,851.00 $0.00 $0
2026-05-05 Kirk Sigurd A-Award 4,851.00 $0.00 $0
2026-05-05 MCKEE WILLIAM A-Award 4,851.00 $0.00 $0
2026-05-05 Mason Heather L A-Award 4,851.00 $0.00 $0
2026-03-02 Schlessinger Sam A-Award 21,128.00 $11.77 $248,677
2026-03-02 Schlessinger Sam A-Award 18,804.00 $0.00 $0
2026-03-02 Patel Ajay A-Award 21,128.00 $11.77 $248,677
2026-03-02 Patel Ajay A-Award 18,804.00 $0.00 $0
2026-03-02 Schwichtenberg Paul A-Award 27,888.00 $11.77 $328,242
2026-03-02 Schwichtenberg Paul A-Award 24,820.00 $0.00 $0
2026-03-02 Reisenauer Mark L A-Award 26,667.00 $11.77 $313,871
2026-02-21 Schlessinger Sam M-Exempt 1,143.00 $0.00 $0
2026-02-21 Schlessinger Sam F-InKind 510.00 $11.84 $6,038
2026-02-21 Schlessinger Sam M-Exempt 1,143.00 $0.00 $0
2026-02-21 Patel Ajay M-Exempt 1,143.00 $0.00 $0
2026-02-21 Patel Ajay F-InKind 566.00 $11.84 $6,701
2026-02-21 Patel Ajay M-Exempt 1,143.00 $0.00 $0
2026-02-21 Schwichtenberg Paul M-Exempt 1,143.00 $0.00 $0
2026-02-21 Schwichtenberg Paul F-InKind 566.00 $11.84 $6,701
Community AI Feedback
Sign in to Contribute
No community reviews yet for ASRT. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27